Van der Heijden et al. [8] constructed a five-gene expression signature including SPOCD1, which had a 79% sensitivity and an 86% specificity (AUC = 0.83) for distinguishing between individuals with the progressive condition regarding T1G3 bladder cancer and those without. The gene discussed is SPOCD1; the disease is urinary bladder cancer.